Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2025-12-29 @ 7:32 PM
Study NCT ID:
NCT01684657
Status:
SUSPENDED
Last Update Posted:
2014-05-20
First Post:
2012-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Sponsor:
University of California, Irvine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2014-05
Completion Date Type:
ESTIMATED
First Submit Date:
2012-07-24
First Submit QC Date:
None
Study First Post Date:
2012-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-19
Last Update Post Date:
2014-05-20
Last Update Post Date Type:
ESTIMATED